ZWA-37975-67237
3 vaccinations
1 coded response
26 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 750 / TX
- Registered
- 2021-01-09
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-09
Registered in v-safe
-
2021-01-09
Dose 1 — Moderna
-
2021-01-09
Health check-in — day 0, dose 1Feeling: Good · Site: Swelling · Fatigue or tirednessAdult check-in
- 2021-01-10
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-15
- 2021-01-16
- 2021-01-23
- 2021-01-30
-
2021-02-05
Dose 2 — Moderna
-
2021-02-06
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Chills, Muscle or body achesAdult check-in
-
2021-02-07
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Swelling · Muscle or body achesAdult check-in
- 2021-02-08
- 2021-02-09
- 2021-02-10
- 2021-02-11
- 2021-02-12
- 2021-02-19
- 2021-02-26
- 2021-03-06
- 2021-03-12
- 2021-03-19
- 2021-05-07
- 2021-08-06
-
2021-11-16
Dose 3 — Moderna
-
2022-02-05
Survey response — 12 months, dose 2MedDRA: Dyspnoea, Fatigue, Oropharyngeal pain, Pain — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Fatigue, sore throat, generalized body pains and breathlessnessMedDRA releases: 2024-11 · check-in free text available
-
2022-02-05
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-03-30
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2022-11-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-09 | Moderna | |
| 2 | 2021-02-05 | Moderna | |
| 3 | 2021-11-16 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-02-05 | Successful 2022-03-30 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 11 — 12 months, dose 2
Symptoms: Fatigue, sore throat, generalized body pains and breathlessness
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dyspnoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release